-
Something wrong with this record ?
Aktivace regulačních T lymfocytů hraje důležitou roli v navození remise idiopatického nefrotického syndromu
[Induction of T regulatory cells attenuates idiopathic nephrotic syndrome]
Le Berre L, Bruneau S, Naulet J, et al.
Language Czech Country Czech Republic
- MeSH
- Cytokines genetics MeSH
- Glomerulosclerosis, Focal Segmental drug therapy immunology MeSH
- Guanidines therapeutic use MeSH
- Immunosuppressive Agents therapeutic use MeSH
- Rats MeSH
- Antibodies, Monoclonal therapeutic use MeSH
- Nephrotic Syndrome drug therapy immunology MeSH
- NF-kappa B physiology MeSH
- Adoptive Transfer MeSH
- Receptors, Antigen, T-Cell physiology MeSH
- Recurrence MeSH
- T-Lymphocytes, Regulatory immunology drug effects MeSH
- Kidney Transplantation adverse effects MeSH
- Animals MeSH
- Check Tag
- Rats MeSH
- Male MeSH
- Animals MeSH
Buffalo/Mna rats spontaneously develop FSGS and nephrotic syndrome as a result of an immune disorder. Similar to some humans with FSGS, the disease recurs after renal transplantation, suggesting the involvement of a circulating factor. Here, we tested the effect of several immunosuppressive treatments on these rats. Although corticosteroids, cyclosporin A, and anti-T cell receptor treatment reduced proteinuria, only the deoxyspergualin derivative LF15-0195 led to a rapid and complete normalization of proteinuria. Furthermore, this compound led to the regression of renal lesions during both the initial disease and posttransplantation recurrence. The frequency of splenic and peripheral CD4+CD25+FoxP3+ T lymphocytes significantly increased with remission. Moreover, the transfer of purified LF15-0195-induced CD4+CD25+ T cells to irradiated Buff/Mna rats significantly reduced their proteinuria compared with the transfer of untreated control cells, suggesting that LF15-0195 induces regulatory T cells that are able to induce regression of rat nephropathy. These data suggest that idiopathic nephrotic syndrome/FSGS disease can be regulated by cellular transfer, but how this regulation leads to the reorganization of the podocyte cytoskeleton remains to be determined.
Induction of T regulatory cells attenuates idiopathic nephrotic syndrome
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07518686
- 003
- CZ-PrNML
- 005
- 20111210130548.0
- 008
- 090302s2008 xr e cze||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a cze $b eng
- 044 __
- $a xr
- 100 1_
- $a Le Berre, L.
- 245 10
- $a Aktivace regulačních T lymfocytů hraje důležitou roli v navození remise idiopatického nefrotického syndromu / $c Le Berre L, Bruneau S, Naulet J, et al.
- 246 11
- $a Induction of T regulatory cells attenuates idiopathic nephrotic syndrome
- 314 __
- $a INSERM U643, CHU Hôtel Dieu, 30 Bd Jean Monnet, Nantes
- 520 9_
- $a Buffalo/Mna rats spontaneously develop FSGS and nephrotic syndrome as a result of an immune disorder. Similar to some humans with FSGS, the disease recurs after renal transplantation, suggesting the involvement of a circulating factor. Here, we tested the effect of several immunosuppressive treatments on these rats. Although corticosteroids, cyclosporin A, and anti-T cell receptor treatment reduced proteinuria, only the deoxyspergualin derivative LF15-0195 led to a rapid and complete normalization of proteinuria. Furthermore, this compound led to the regression of renal lesions during both the initial disease and posttransplantation recurrence. The frequency of splenic and peripheral CD4+CD25+FoxP3+ T lymphocytes significantly increased with remission. Moreover, the transfer of purified LF15-0195-induced CD4+CD25+ T cells to irradiated Buff/Mna rats significantly reduced their proteinuria compared with the transfer of untreated control cells, suggesting that LF15-0195 induces regulatory T cells that are able to induce regression of rat nephropathy. These data suggest that idiopathic nephrotic syndrome/FSGS disease can be regulated by cellular transfer, but how this regulation leads to the reorganization of the podocyte cytoskeleton remains to be determined.
- 650 _2
- $a převzatá imunita $7 D019264
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a monoklonální protilátky $x terapeutické užití $7 D000911
- 650 _2
- $a cytokiny $x genetika $7 D016207
- 650 _2
- $a fokálně segmentální glomeruloskleróza $x farmakoterapie $x imunologie $7 D005923
- 650 _2
- $a guanidiny $x terapeutické užití $7 D006146
- 650 _2
- $a imunosupresiva $x terapeutické užití $7 D007166
- 650 _2
- $a transplantace ledvin $x škodlivé účinky $7 D016030
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a NF-kappa B $x fyziologie $7 D016328
- 650 _2
- $a nefrotický syndrom $x farmakoterapie $x imunologie $7 D009404
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a receptory antigenů T-buněk $x fyziologie $7 D011948
- 650 _2
- $a recidiva $7 D012008
- 650 _2
- $a regulační T-lymfocyty $x imunologie $x účinky léků $7 D050378
- 700 1_
- $a Bruneau, S.
- 700 1_
- $a Naulet, J.
- 773 0_
- $w MED00012709 $t Postgraduální nefrologie $g Roč. 6, č. 6 (2008), s. 83-84 $x 1214-178X
- 787 18
- $w bmc07518688 $i Recenze v: $t Komentář [k článku Aktivace regulačních T lymfocytů hraje důležitou roli v navození remise idiopatického nefrotického syndromu]
- 856 41
- $y plný text volně přístupný $u https://www.postgradualninefrologie.cz/download/format/pdf/id/242/
- 910 __
- $a ABA008 $b B 2318 $c 893 $y 9
- 990 __
- $a 20090302143519 $b ABA008
- 991 __
- $a 20090401103138 $b ABA008
- 999 __
- $a ok $b bmc $g 636498 $s 489230
- BAS __
- $a 3
- BMC __
- $a 2008 $b 6 $c 6 $d 83-84 $i 1214-178X $m Postgraduální nefrologie $x MED00012709
- LZP __
- $a 2009-10/mkme